Trials / Completed
CompletedNCT00002015
An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Roche Global Development · Academic / Other
- Sex
- All
- Age
- 3 Months – 12 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the pharmacokinetics of intravenous ganciclovir in children (ages 3 months - 12 years). To determine the safety and tolerance of a 2 to 3 week induction course of ganciclovir IV in immunocompromised children receiving treatment for life- or sight-threatening cytomegalovirus infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ganciclovir |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002015. Inclusion in this directory is not an endorsement.